XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Investment - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)   251,277,515     251,277,515      
Beginning balance   $ 1,938,087,820   $ 1,861,751,660 $ 1,938,087,820 $ 1,861,751,660 $ 2,049,518,261  
Issuance of common stock from stock plan transactions         41,803,640 77,821,151 66,837,820  
Issuance of common stock related to acquisitions         3,559,229      
Repurchases of common stock         (288,480,506) (331,471,392) (591,577,851)  
Stock-based compensation expense related to stock options, employee stock purchases and restricted stock         30,797,327 21,671,192 18,305,981  
Accounting standards update               us-gaap:AccountingStandardsUpdate201601Member
Dividends declared         (117,528,158) (116,679,965) (117,064,654)  
Net income $ 143,339,000 $ 89,506,000 $ 99,547,000 $ 104,280,000 347,563,621 424,683,939 437,883,097  
Other comprehensive income         $ 8,140,155 $ 311,235 (2,150,994)  
Ending balance (in shares) 243,692,869   251,277,515   243,692,869 251,277,515    
Ending balance $ 1,963,943,128   $ 1,938,087,820   $ 1,963,943,128 $ 1,938,087,820 1,861,751,660 $ 2,049,518,261
Cumulative Effect, Period of Adoption, Adjustment                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance             $ 0  
Ending balance               $ 0
Common Stocks                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)   251,277,515   259,328,613 251,277,515 259,328,613 280,281,321  
Beginning balance   $ 15,076,651   $ 15,559,717 $ 15,076,651 $ 15,559,717 $ 16,816,879  
Issuance of common stock from stock plan transactions (in shares)         2,897,689 5,724,840 5,496,659  
Issuance of common stock from stock plan transactions         $ 173,861 $ 343,490 $ 329,801  
Issuance of common stock related to acquisitions (in shares)         163,718      
Issuance of common stock related to acquisitions         $ 9,823      
Repurchases of common stock (in shares)         (10,646,053) (13,775,938) (26,449,367)  
Repurchases of common stock         $ (638,763) $ (826,556) $ (1,586,963)  
Ending balance (in shares) 243,692,869   251,277,515   243,692,869 251,277,515 259,328,613 280,281,321
Ending balance $ 14,621,572   $ 15,076,651   $ 14,621,572 $ 15,076,651 $ 15,559,717 $ 16,816,879
Additional  Paid-In Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance   807,928,139   745,324,144 807,928,139 745,324,144 723,510,672  
Issuance of common stock from stock plan transactions         41,629,779 77,477,661 66,508,019  
Issuance of common stock related to acquisitions         3,549,406      
Repurchases of common stock         (31,133,143) (36,544,858) (63,000,528)  
Stock-based compensation expense related to stock options, employee stock purchases and restricted stock         30,797,327 21,671,192 18,305,981  
Ending balance 852,771,508   807,928,139   852,771,508 807,928,139 745,324,144 723,510,672
Retained  Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance   1,116,372,133   1,102,468,137 1,116,372,133 1,102,468,137 1,301,997,327  
Repurchases of common stock         (256,708,600) (294,099,978) (526,990,360)  
Dividends declared         (117,528,158) (116,679,965) (117,064,654)  
Net income         347,563,621 424,683,939 437,883,097  
Ending balance 1,089,698,996   1,116,372,133   1,089,698,996 1,116,372,133 1,102,468,137 1,301,997,327
Retained  Earnings | Cumulative Effect, Period of Adoption, Adjustment                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance             6,642,727  
Ending balance               6,642,727
Accumulated  Other Comprehensive Income (Loss)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance   $ (1,289,103)   $ (1,600,338) (1,289,103) (1,600,338) 7,193,383  
Other comprehensive income         8,140,155 311,235 (2,150,994)  
Ending balance $ 6,851,052   $ (1,289,103)   $ 6,851,052 $ (1,289,103) (1,600,338) 7,193,383
Accumulated  Other Comprehensive Income (Loss) | Cumulative Effect, Period of Adoption, Adjustment                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance             $ (6,642,727)  
Ending balance               $ (6,642,727)